Decoy Therapeutics Inc.
DCOY | NASDAQ
$1.07
$0.00 (0.00%)
Nov 2, 2026, 9:49 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -14.45M | -13.03M | -12.52M | -5M | -5.1M | -5.57M | -5.58M | -4.99M | -6.46M | -8.92M | -12.54M | -18.03M | -30M | -30.84M | -31.61M | -29.34M | -18.67M | -17.03M | -12.77M | -10.43M | -8.41M | -7.12M |
Depreciation & Amortization | 24.5K | 11.97K | 7.15K | 4.42K | 4.42K | 4.42K | 4.42K | 4.42K | 8.93K | 9.49K | 10.05K | 10.62K | 6.68K | 3.55K | 6.68K | 9.8K | 12.93K | 19.19K | 19.18K | 19.75K | 19.18K | 18.62K |
Stock-Based Compensation | 442.07K | 259.05K | 79.54K | 130.58K | 167.74K | 229.76K | 273.73K | 308.06K | 360.71K | 399K | 524.84K | 584.97K | 610.18K | 686.25K | 796.8K | 797.19K | 789.64K | 737.57K | 559.04K | 582.88K | 530.91K | 416.36K |
Other Working Capital | -706.27K | -686.08K | 431.56K | -50.95K | 132.55K | 505.06K | 438.15K | 309.95K | -154.35K | 120.01K | -193.35K | 409.39K | 601.42K | 771.59K | 1.04M | 1.16M | 786.95K | 474.22K | 99.66K | -114.39K | 695.6K | 459.07K |
Other Non-Cash Items | 8.1M | 8.34M | 8.34M | -310.84K | n/a | n/a | n/a | 573.37K | 703.37K | 609.29K | -1.29M | -1.87M | 6.87M | 6.96M | 10.85M | 10.81M | 1.94M | 1.9M | -44.69K | -23.22K | -59.25K | 70.57K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -573.37K | -573.37K | -479.29K | 1.42M | 2M | 2M | 1.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -2.45M | -2.11M | -735.5K | 747.38K | 788.05K | 982.75K | 772.29K | -612.89K | -1.72M | -2.65M | -968.33K | 1.26M | 2.48M | 4.04M | 2.36M | 2.12M | 4.48M | 3.37M | 2.03M | 998.42K | -2.1M | -2.71M |
Operating Cash Flow | -8.32M | -6.53M | -4.83M | -4.43M | -4.14M | -4.35M | -4.53M | -5.29M | -7.69M | -11.03M | -12.85M | -16.05M | -18.04M | -17.24M | -17.6M | -15.6M | -11.44M | -11M | -10.2M | -8.85M | -10.02M | -9.33M |
Capital Expenditures | -42.43K | -2 | 2 | 4 | 4 | 4 | -5 | -5 | -9 | -9 | -4 | -4 | n/a | n/a | -1.5M | -1.5M | -1.5M | -1.5M | n/a | n/a | n/a | n/a |
Cash Acquisitions | 1.34M | 1.34M | 1.34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -200K | -200K | -200K | -200K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -377K | -377K | -377K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.6K | -2.6K | -2.6K |
Investing Cash Flow | 722.31K | 764.74K | 764.74K | -200K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.5M | -1.5M | -1.5M | -1.5M | n/a | -2.6K | -2.6K | -2.6K |
Debt Repayment | n/a | -112.23K | -221.87K | -328.85K | -398.73K | -403.35K | -466.51K | -528.97K | -570.56K | -453.71K | -280.92K | -111.47K | n/a | n/a | n/a | n/a | n/a | -191.4K | -477.03K | -761.1K | -949.13K | -1.01M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -85.69 | -85.69 | -85.69 | -85.69 | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2 | 2 | 2 | 1.49M | 4.72M | 4.78M | 5.35M |
Financial Cash Flow | 15.1M | 11.79M | 12.34M | 6.16M | 1.67M | 1.78M | 1.06M | 997.49K | -582.22K | 6.13M | 6.64M | 6.81M | 6.94M | 2.32M | 1.99M | 2.02M | 2.51M | 79.5K | 28.3M | 31.2M | 35.88M | 36.29M |
Net Cash Flow | 7.49M | 6.02M | 8.28M | 1.53M | -2.48M | -2.57M | -3.47M | -4.3M | -8.27M | -4.9M | -6.21M | -9.24M | -11.11M | -14.92M | -17.11M | -15.08M | -10.43M | -12.42M | 18.1M | 22.35M | 25.86M | 26.97M |
Free Cash Flow | -8.37M | -6.53M | -4.83M | -4.43M | -4.14M | -4.35M | -4.53M | -5.29M | -7.69M | -11.03M | -12.85M | -16.05M | -18.04M | -17.24M | -19.1M | -17.1M | -12.94M | -12.5M | -10.2M | -8.86M | -10.03M | -9.33M |
Adj. Free Cash Flow | -8.81M | -6.79M | -4.91M | -4.56M | -4.31M | -4.58M | -4.8M | -5.6M | -8.05M | -11.43M | -13.37M | -16.63M | -18.65M | -17.93M | -19.89M | -17.9M | -13.73M | -13.24M | -10.76M | -9.44M | -10.56M | -9.75M |
Maintenance CapEx | -13.63K | -2 | 2 | 4 | 4 | 4 | -5 | -5 | -9 | -9 | -4 | -4 | n/a | n/a | -1.5M | -1.5M | -1.5M | -1.5M | n/a | n/a | n/a | n/a |
Growth CapEx | -28.79K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -8.34M | -6.53M | -4.83M | -4.43M | -4.14M | -4.35M | -4.53M | -5.29M | -7.69M | -11.03M | -12.85M | -16.05M | -18.04M | -17.24M | -19.1M | -17.1M | -12.94M | -12.5M | -10.2M | -8.85M | -10.02M | -9.33M |
Add to Watchlist
Select watchlists to add or remove DCOY